-
2024-513191-17-00
4
2022-02-03
autoimmune hemolytic anemia
-
2024-512631-77-00
4
2021-12-20
locally advanced or metastatic Gastrointestinal Stromal Tumors
-
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
-
2024-511904-18-00
10
2020-07-08
Pancreatic adenocarcinoma (PAC)
-
2024-510580-28-00
5
2019-06-05
Middle or low locally advanced resectable rectal carcinoma
-
2024-512034-14-00
5
2019-03-04
severe trauma
-
2024-514094-22-00
5
2019-01-18
Intrecerebral Haemorrhage
-
2024-516110-38-00
5
2018-03-06
Hepatoblastoma and Hepatocellular Carcinoma
-
2024-518578-15-00
5
2018-02-05
Is to demonstrate a non inferior efficacy of azithromycin and so the p
-
2024-515432-71-00
5
2016-09-13
gastrointestinal stromal tumor
-
2024-516103-16-00
4
2015-12-04
Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years)
-
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
-
2023-506027-29-00
5
2014-10-01
Children, adolescents and adults with newly diagnosed diffuse intrinsi
-
2025-521302-17-00
10
2026-05-26
Hihg risk of cholangiocarcinoma intra hépatic resectable
-
2024-516873-57-00
10
2026-01-13
Acute myeloid leukemia in adults aged 18 to 60
-
2024-512914-16-00
5
2025-09-12
Relapsing-remitting Multiple Sclerosis
-
2024-514228-18-00
4
2025-01-16
Asthma in adults who remain uncontrolled despite medium to high dose I
-
2023-508077-85-00
5
2024-11-19
Polymyalgia Rheumatica
-
2023-508636-61-00
5
2024-10-24
Crohn’s Disease
-
2023-505278-13-00
4
2024-10-01
-women with an inflammatory HCA proven at histology and with at least
-
2022-502781-24-01
5
2024-06-05
ASCVD - Atherosclerotic Cardiovascular Disease
-
2023-508085-15-00
5
2024-05-15
Chronic Obstructive Pulmonary Disease
-
2023-503235-18-00
4
2024-01-31
previously untreated WM
-
2023-505976-31-00
5
2023-11-24
Systemic Sclerosis (SSc) presenting with Limited or Diffuse Cutaneous